364 related articles for article (PubMed ID: 32373992)
1. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment.
Wang XY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4537-4538. PubMed ID: 32373992
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
Zayed M; Iohara K
Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cell Therapy Can Transcend Perianal Crohn's Disease: How Colorectal Surgeons Can Help in the Coronavirus Disease 2019 Crisis.
Lightner AL; García-Olmo D
Dis Colon Rectum; 2020 Jul; 63(7):874-878. PubMed ID: 32251143
[No Abstract] [Full Text] [Related]
4. Mesenchymal stem cell research progress for the treatment of COVID-19.
Yao D; Ye H; Huo Z; Wu L; Wei S
J Int Med Res; 2020 Sep; 48(9):300060520955063. PubMed ID: 32972277
[TBL] [Abstract][Full Text] [Related]
5. Overview of Stem Cell Therapy for Acute Respiratory Distress Syndrome with Focus on COVID 19.
Kaye RJ
Pain Physician; 2020 Aug; 23(4S):S421-S432. PubMed ID: 32942797
[TBL] [Abstract][Full Text] [Related]
6. [Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review].
Shi X; Yu L; Ding C
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1979-1991. PubMed ID: 33169564
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
[TBL] [Abstract][Full Text] [Related]
8. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM
Cells; 2020 Sep; 9(9):. PubMed ID: 32887260
[TBL] [Abstract][Full Text] [Related]
9. Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients.
Convertino I; Tuccori M; Ferraro S; Valdiserra G; Cappello E; Focosi D; Blandizzi C
Crit Care; 2020 Jun; 24(1):331. PubMed ID: 32527304
[TBL] [Abstract][Full Text] [Related]
10. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19.
Khoury M; Cuenca J; Cruz FF; Figueroa FE; Rocco PRM; Weiss DJ
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32265310
[TBL] [Abstract][Full Text] [Related]
11. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
12. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential.
Khoury M; Rocco PRM; Phinney DG; Krampera M; Martin I; Viswanathan S; Nolta JA; LeBlanc K; Galipeau J; Weiss DJ
Cytotherapy; 2020 Nov; 22(11):602-605. PubMed ID: 32933835
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
Pan C; Xie JF; Qiu HB; Yang Y
Zhonghua Shao Shang Za Zhi; 2020 May; 36(5):330-333. PubMed ID: 32456368
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
[TBL] [Abstract][Full Text] [Related]
15. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
Wang J; Zou W; Liu J
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
[TBL] [Abstract][Full Text] [Related]
16. Awake proning in Covid-19 pneumonia.
Sen MK; Gupta N; Ish P; Kumar R; Yadav SR
Infez Med; 2020 Sep; 28(3):453-455. PubMed ID: 32920584
[TBL] [Abstract][Full Text] [Related]
17. The ARDSnet protocol may be detrimental in COVID-19.
Tsolaki V; Zakynthinos GE; Makris D
Crit Care; 2020 Jun; 24(1):351. PubMed ID: 32546230
[No Abstract] [Full Text] [Related]
18. Weathering the Cytokine Storm in COVID-19: Therapeutic Implications.
Iannaccone G; Scacciavillani R; Del Buono MG; Camilli M; Ronco C; Lavie CJ; Abbate A; Crea F; Massetti M; Aspromonte N
Cardiorenal Med; 2020; 10(5):277-287. PubMed ID: 32599589
[TBL] [Abstract][Full Text] [Related]
19. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
Qu W; Wang Z; Hare JM; Bu G; Mallea JM; Pascual JM; Caplan AI; Kurtzberg J; Zubair AC; Kubrova E; Engelberg-Cook E; Nayfeh T; Shah VP; Hill JC; Wolf ME; Prokop LJ; Murad MH; Sanfilippo FP
Stem Cells Transl Med; 2020 Sep; 9(9):1007-1022. PubMed ID: 32472653
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
Golchin A; Seyedjafari E; Ardeshirylajimi A
Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
